{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:22:05Z","timestamp":1790166125040,"version":"4.1.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,13]],"date-time":"2020-03-13T00:00:00Z","timestamp":1584057600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R21AI129477"],"award-info":[{"award-number":["1R21AI129477"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["201911014359"],"award-info":[{"award-number":["201911014359"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001688","name":"International Centre for Genetic Engineering and Biotechnology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["EBioMedicine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.ebiom.2020.102738","type":"journal-article","created":{"date-parts":[[2020,4,27]],"date-time":"2020-04-27T17:15:42Z","timestamp":1588007742000},"page":"102738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Zika virus envelope nanoparticle antibodies protect mice without risk of disease enhancement"],"prefix":"10.1016","volume":"54","author":[{"given":"Rahul","family":"Shukla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajgokul K.","family":"Shanmugam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viswanathan","family":"Ramasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upasana","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua A.","family":"Acklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Krammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean K.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathyamangalam","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navin","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2020.102738_bib0001","series-title":"Fields virology","first-page":"747","article-title":"Flaviviruses","author":"Pierson","year":"2013"},{"key":"10.1016\/j.ebiom.2020.102738_bib0002","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41586-018-0446-y","article-title":"The emergence of Zika virus and its new clinical syndromes","volume":"560","author":"Pierson","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.102738_bib0003","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1099\/jgv.0.000381","article-title":"Zika virus: a previously slow pandemic spreads rapidly through the Americas","volume":"97","author":"Gatherer","year":"2016","journal-title":"J Gen Virol"},{"key":"10.1016\/j.ebiom.2020.102738_bib0004","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1128\/JVI.00252-16","article-title":"Zika virus: new clinical syndromes and its emergence in the Western hemisphere","volume":"90","author":"Lazear","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2020.102738_bib0005","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3201\/eid2102.141363","article-title":"Potential sexual transmission of Zika virus","volume":"21","author":"Musso","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"13","key":"10.1016\/j.ebiom.2020.102738_bib0006","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2014.19.13.20751","article-title":"Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014","volume":"19","author":"Besnard","year":"2014","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ebiom.2020.102738_bib0007","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1056\/NEJMoa1600651","article-title":"Zika virus associated with microcephaly","volume":"374","author":"Mlakar","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2020.102738_bib0008","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0140-6736(17)31450-2","article-title":"An update on Zika virus infection","volume":"390","author":"Baud","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2020.102738_bib0009","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf8160","article-title":"Assessing the global threat from Zika virus","volume":"353","author":"Lessler","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2020.102738_bib0010","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMsr1604338","article-title":"Zika virus and birth defects-reviewing the evidence for causality","volume":"374","author":"Rasmussen","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2020.102738_bib0011","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1056\/NEJMe1601862","article-title":"Zika virus and microcephaly","volume":"374","author":"Rubin","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2020.102738_bib0012","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S1473-3099(16)00095-5","article-title":"Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study","volume":"16","author":"Calvet","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2020.102738_bib0013","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(16)00562-6","article-title":"Guillain-Barre syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study","volume":"387","author":"Cao-Lormeau","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2020.102738_bib0014","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.stem.2016.02.016","article-title":"Zika virus infects human cortical neural progenitors and attenuates their growth","volume":"18","author":"Tang","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ebiom.2020.102738_bib0015","doi-asserted-by":"crossref","first-page":"e15272","DOI":"10.7554\/eLife.15272","article-title":"Mapping global environmental suitability for Zika virus","volume":"5","author":"Messina","year":"2016","journal-title":"eLife"},{"key":"10.1016\/j.ebiom.2020.102738_bib0016","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.aag0219","article-title":"Countering the Zika epidemic in Latin America","volume":"353","author":"Ferguson","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2020.102738_bib0017","first-page":"594","article-title":"Zika virus vaccines","volume":"16","author":"Abbink","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.102738_bib0018","first-page":"1003","article-title":"Vaccine against Zika virus must remain a priority","volume":"17","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2020.102738_bib0019","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/imr.12367","volume":"268","author":"Taylor","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1016\/j.ebiom.2020.102738_bib0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.antiviral.2016.03.010","article-title":"Zika virus: history, emergence, biology, and prospects for control","volume":"130","author":"Weaver","year":"2016","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ebiom.2020.102738_bib0021","doi-asserted-by":"crossref","first-page":"584","DOI":"10.4269\/ajtmh.2012.11-0770","article-title":"Review: the history of dengue outbreaks in the Americas","volume":"87","author":"Brathwaite Dick","year":"2012","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ebiom.2020.102738_bib0022","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1017\/S0950268812001367","article-title":"Force of infection of dengue serotypes in a population-based study in northeast Brazil","volume":"141","author":"Castanha","year":"2013","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.ebiom.2020.102738_bib0023","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.actatropica.2009.10.021","article-title":"Seroprevalence and risk factors for dengue infection in socio-economically distinct areas of Recife, Brazil","volume":"113","author":"Braga","year":"2010","journal-title":"Acta Trop"},{"key":"10.1016\/j.ebiom.2020.102738_bib0024","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1126\/science.aal4365","article-title":"Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity","volume":"356","author":"Bardina","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2020.102738_bib0025","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/ni.3515","article-title":"Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with Zika virus","volume":"17","author":"Dejnirattisai","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ebiom.2020.102738_bib0026","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/S1473-3099(18)30063-X","article-title":"Development of vaccines against Zika virus","volume":"18","author":"Poland","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ebiom.2020.102738_bib0027","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s12916-018-1067-x","article-title":"Zika vaccines and therapeutics: landscape analysis and challenges ahead","volume":"16","author":"Wilder-Smith","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.ebiom.2020.102738_bib0028","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41541-018-0061-9","article-title":"Current status of Zika vaccine development: Zika vaccines advance into clinical evaluation","volume":"3","author":"Barrett","year":"2018","journal-title":"npj Vaccines"},{"key":"10.1016\/j.ebiom.2020.102738_bib0029","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.coi.2018.04.024","article-title":"Zika virus vaccines: immune response, current status, and future challenges","volume":"53","author":"Richner","year":"2018","journal-title":"Current Opin Immunol"},{"key":"10.1016\/j.ebiom.2020.102738_bib0030","article-title":"The World Health Organization","year":"2020","journal-title":"Vaccine pipeline tracker"},{"key":"10.1016\/j.ebiom.2020.102738_bib0031","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2016.07.020","article-title":"Structural basis of Zika virus-specific antibody protection","volume":"166","author":"Zhao","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.ebiom.2020.102738_bib0032","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.aaf8505","article-title":"Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection","volume":"353","author":"Stettler","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2020.102738_bib0033","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aai8336","article-title":"Molecular determinants of human neutralizing antibodies isolated from a patient infected with Zika virus","volume":"8","author":"Wang","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2020.102738_bib0034","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.chom.2016.04.013","article-title":"Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody","volume":"19","author":"Dai","year":"2016","journal-title":"Cell Host Microb"},{"key":"10.1016\/j.ebiom.2020.102738_bib0035","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1126\/science.aaf5316","article-title":"The 3.8 \u00c5 resolution cryo-EM structure of Zika virus","volume":"352","author":"Sirohi","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2020.102738_bib0036","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nature17994","article-title":"Structure of the thermally stable Zika virus","volume":"533","author":"Kostyuchenko","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.102738_bib0037","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1126\/science.aam7120","article-title":"A single mutation in the prM protein of Zika virus contributes to fetal microcephaly","volume":"358","author":"Yuan","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2020.102738_bib0038","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1126\/science.aaq1297","article-title":"Evolution of neurovirulent Zika virus","volume":"358","author":"Screaton","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2020.102738_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006210","article-title":"Zika virus like particles elicit protective antibodies in mice","volume":"12","author":"Salvo","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ebiom.2020.102738_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005608","article-title":"Zika virus-like particle (VLP) based vaccine","volume":"11","author":"Boigard","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ebiom.2020.102738_bib0041","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00834-17","article-title":"Development of virus-like-particle vaccine and reporter assay for Zika virus","volume":"91","author":"Garg","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2020.102738_bib0042","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01181-17","article-title":"An envelope-modified tetravalent dengue virus-like particle vaccine has implications for flavivirus vaccine design","volume":"91","author":"Urakami","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2020.102738_bib0043","doi-asserted-by":"crossref","first-page":"e64595","DOI":"10.1371\/journal.pone.0064595","article-title":"Pichia pastoris-expressed Dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies","volume":"8","author":"Mani","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2020.102738_bib0044","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3389\/fmicb.2015.01005","article-title":"Pichia pastoris-expressed Dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies","volume":"6","author":"Tripathi","year":"2015","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ebiom.2020.102738_bib0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12896-016-0280-y","article-title":"Virus-like particles derived from Pichia pastoris-expressed Dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies","volume":"16","author":"Poddar","year":"2016","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.ebiom.2020.102738_bib0046","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4269\/ajtmh.16-0503","article-title":"Recombinant Dengue virus 4 envelope glycoprotein virus-like particles derived from Pichia pastoris are capable of eliciting homotypic domain III-directed neutralizing antibodies","volume":"96","author":"Khetarpal","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ebiom.2020.102738_bib0047","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nature20564","article-title":"Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice","volume":"540","author":"Sapparapu","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.102738_bib0048","article-title":"Pichia pastoris-expressed Zika virus envelope domain III on a virus-like particle platform: design, production and immunological evaluation","volume":"77","author":"Shanmugam","year":"2019","journal-title":"Pathogens Dis"},{"key":"10.1016\/j.ebiom.2020.102738_bib0049","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006191","article-title":"A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice","volume":"12","author":"Ramasamy","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ebiom.2020.102738_bib0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006258","article-title":"A novel Zika virus mouse model reveals strain specific differences in virus pathogenesis and host inflammatory immune responses","volume":"13","author":"Tripathi","year":"2017","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ebiom.2020.102738_bib0051","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1128\/JCM.00827-07","article-title":"Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization","volume":"45","author":"Kraus","year":"2007","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ebiom.2020.102738_bib0052","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jbiosc.2010.05.001","article-title":"Optimization of conditions for secretion of dengue virus type 2 envelope domain III using Pichia pastoris","volume":"110","author":"Batra","year":"2010","journal-title":"J Biosci Bioengg"},{"key":"10.1016\/j.ebiom.2020.102738_bib0053","doi-asserted-by":"crossref","first-page":"830","DOI":"10.4269\/ajtmh.1982.31.830","article-title":"Dengue virus-specific and flavivirus group determinants identified with monoclonal antibodies by indirect immunofluorescence","volume":"3","author":"Henchal","year":"1982","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.ebiom.2020.102738_bib0054","doi-asserted-by":"crossref","first-page":"5847","DOI":"10.1128\/JVI.00216-15","article-title":"Dengue virus infection with highly neutralizing levels of cross-reactive antibodies causes acute lethal small intestinal pathology without a high level of viremia in mice","volume":"89","author":"Watanabe","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.ebiom.2020.102738_bib0055","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1128\/JCM.00975-17","article-title":"Evaluation of a novel reporter virus neutralization test for serological diagnosis of Zika and dengue virus infection","volume":"55","author":"Shan","year":"2017","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ebiom.2020.102738_bib0056","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ebiom.2017.03.006","article-title":"A rapid Zika diagnostic assay to measure neutralizing antibodies in patients","volume":"17","author":"Shan","year":"2017","journal-title":"EBioMed"},{"key":"10.1016\/j.ebiom.2020.102738_bib0057","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.3389\/fmicb.2017.02644","article-title":"Pichia pastoris-expressed bivalent virus-like particulate vaccine induces domain III-focused bivalent neutralizing antibodies without antibody-dependent enhancement","volume":"8","author":"Shukla","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.ebiom.2020.102738_bib0058","doi-asserted-by":"crossref","first-page":"8643","DOI":"10.1038\/s41598-018-26904-5","article-title":"Dengue envelope-based \u2018four-in-one\u2019 virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralizing antibodies in mice","volume":"8","author":"Rajpoot","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2020.102738_bib0059","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.chom.2007.03.002","article-title":"The stoichiometry of antibody-mediated neutralization and enhancement of West Nile virus infection","volume":"1","author":"Pierson","year":"2007","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ebiom.2020.102738_bib0060","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.chom.2018.09.015","article-title":"Maternally acquired Zika antibodies enhance Dengue disease severity in mice","volume":"24","author":"Fowler","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ebiom.2020.102738_bib0061","doi-asserted-by":"crossref","first-page":"10498","DOI":"10.1038\/s41598-017-10901-1","article-title":"Prior exposure to Zika virus significantly enhances peak Dengue-2 viremia in Rhesus macaques","volume":"7","author":"George","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2020.102738_bib0062","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100641","article-title":"Characterization of the ectodomain of the envelope protein of dengue virus type 4: expression, membrane association, secretion and particle formation in the absence of precursor membrane protein","volume":"9","author":"Hsieh","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2020.102738_bib0063","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ebiom.2017.12.010","article-title":"Passive transfer of immune sera induced by a Zika virus-like particle vaccine protects AG129 mice against lethal Zika virus challenge","volume":"27","author":"Espinosa","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ebiom.2020.102738_bib0064","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.aah6157","article-title":"Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys","volume":"353","author":"Abbink","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.ebiom.2020.102738_bib0065","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/nature18952","article-title":"Vaccine protection against Zika virus from Brazil","volume":"536","author":"Larocca","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2020.102738_bib0066","doi-asserted-by":"crossref","first-page":"46375","DOI":"10.1038\/srep46375","article-title":"Protective efficacy of Zika vaccine in AG129 mouse model","volume":"7","author":"Sumathy","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2020.102738_bib0067","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.immuni.2019.01.005","article-title":"Dengue virus immunity increases Zika virus-induced damage during pregnancy","volume":"50","author":"Brown","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.ebiom.2020.102738_bib0068","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2017.07.001","article-title":"The immunopathology of dengue and Zika virus infections","volume":"48","author":"Culshaw","year":"2017","journal-title":"Current Opin Immunol"},{"key":"10.1016\/j.ebiom.2020.102738_bib0069","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1038\/ni.3539","article-title":"Immunogenic cross-talk between dengue and Zika viruses","volume":"17","author":"Harrison","year":"2016","journal-title":"Nature Immunol"},{"key":"10.1016\/j.ebiom.2020.102738_bib0070","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.copbio.2013.02.024","article-title":"New opportunities by synthetic biology for biopharmaceutical production in Pichia pastoris","volume":"24","author":"Vogl","year":"2013","journal-title":"Current Opin Biotechnol"},{"key":"10.1016\/j.ebiom.2020.102738_bib0071","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.1007\/s00253-014-5732-5","article-title":"Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production","volume":"98","author":"Ahmad","year":"2014","journal-title":"Appl Microbiol Biotechnol"}],"updated-by":[{"DOI":"10.1016\/j.ebiom.2021.103295","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000}}],"container-title":["EBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420301134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396420301134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:32:28Z","timestamp":1778873548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396420301134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":71,"alternative-id":["S2352396420301134"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102738","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zika virus envelope nanoparticle antibodies protect mice without risk of disease enhancement","name":"articletitle","label":"Article Title"},{"value":"EBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2020.102738","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102738"}}